CARDIOPROGRESS
Foundation for the advancement of cardiology

Knowledge, observation, action

The 35th Great Wall International Congress of Cardiology

Welcome message

Registration Fee

Guideline for Abstract’s Submission

Scientific news

Time-Restricted Eating May Help Adults With Metabolic Syndrome Improve Several Health Markers According to a randomized controlled trial, adults with metabolic syndrome and elevated blood sugar levels who eat for a limited time may experience minor improvements in several indicators, including A1c levels, weight, and body fat.

Impact of multiple obesity metrics on hypertensive disorders of pregnancy: a meta-analysis and Mendelian randomisation study This study demonstrates that various obesity measures are causally linked to increased HDP risk and highlights the mediating role of triglycerides. These findings could inform clinical practices and public health strategies aimed at reducing HDP through targeted obesity and triglyceride management.

Optimal treatment of symptomatic patients with low-gradient severe Aortic valve Stenosis and preserved left ventricular ejection fraction (ROTAS trial) The best management of symptomatic patients with low-gradient (LG) severe aortic stenosis (AS) and preserved left ventricular ejection fraction (LVEF) has not been established.

Cardiovascular safety of vitamin B3 administration Scientists recently reported associations between serum levels of the terminal niacin metabolites N1-methyl-2-pyridone-5-carboxamide (2PY) and N1-methyl-4-pyridone-3-carboxamide (4PY) with an increased 3-year incident risk of major adverse cardiovascular events.

Semaglutide Reduces MACE, Death in Participants With CVD, Overweight/Obesity, and Impaired Kidney Function Semaglutide (Wegovy) prevents major cardiac events including death in adults with overweight/obesity and cardiovascular disease (CVD), both with and without impaired kidney function, a subgroup analysis of the Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) trial shows.

Partners

Video resource

Channel "Cardioprogress"

Follow us